A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

  1. Zeidner, J.F.
  2. Lin, T.L.
  3. Vigil, C.E.
  4. Fine, G.
  5. Yair Levy, M.
  6. Nazha, A.
  7. Esteve, J.
  8. Lee, D.J.
  9. Yee, K.
  10. Dalovisio, A.
  11. Wang, E.S.
  12. Bergua Burgues, J.M.
  13. Schriber, J.
  14. Litzow, M.R.
  15. Frankfurt, O.
  16. Castillo, T.B.D.
  17. Bhatt, V.R.
  18. Bhatnagar, B.
  19. Mehta, P.
  20. Dillon, R.
  21. Vicente, M.V.
  22. Anthony, S.
  23. Bearss, D.
  24. Montesinos, P.
  25. Douglas Smith, B.
Revue:
Blood Cancer Journal

ISSN: 2044-5385

Année de publication: 2021

Volumen: 11

Número: 10

Type: Lettre

DOI: 10.1038/S41408-021-00568-3 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus